Literature DB >> 9691508

The PRO-SELF Mouth Aware program: an effective approach for reducing chemotherapy-induced mucositis.

P J Larson1, C Miaskowski, L MacPhail, M J Dodd, D Greenspan, S L Dibble, S M Paul, R Ignoffo.   

Abstract

Many oncology patients receive chemotherapy drugs that have the potential to induce oral mucositis. If mucositis is not prevented, patients will have to manage the problems associated with mucositis: pain, local infection, and decreased ability to take fluids or food. At the time of this writing, clinical approaches for mucositis management are variable and generally ineffective. The mouth care program, PRO-SELF: Mouth Aware (PSMA), presented in this article, was found to be a significant component of a self-care program that may have reduced the incidence of chemotherapy-induced mucositis. The PSMA program has three dimensions: (a) didactic information, (b) development of self-care exercises (skills), and (c) supportive interactions with a nurse in the setting where the patients are receiving their treatment. This program focuses on decreasing the direct (i.e., incidence and severity of mucositis) and indirect morbidities of oral mucositis (i.e., number of local infections, level of discomfort/pain, and disruption in fluid and/or food intake). It provides the critical dimensions (i.e., specific information, self-care exercises, and nurse support) to promote the prevention of mucositis. The PSMA program is designed to provide patients with a definitive self-care repertoire to manage chemotherapy-induced mucositis in the home without the direct supervision of a health care provider.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9691508     DOI: 10.1097/00002820-199808000-00007

Source DB:  PubMed          Journal:  Cancer Nurs        ISSN: 0162-220X            Impact factor:   2.592


  6 in total

Review 1.  Barriers and strategies in implementation of oral care standards for cancer patients.

Authors:  Deborah B McGuire
Journal:  Support Care Cancer       Date:  2003-04-12       Impact factor: 3.603

2.  Multicenter phase II study of an oral care program for patients with head and neck cancer receiving chemoradiotherapy.

Authors:  Tomoya Yokota; Hiroyuki Tachibana; Tetsuhito Konishi; Takashi Yurikusa; Satoshi Hamauchi; Kensuke Sakai; Masaya Nishikawa; Miho Suzuki; Yayoi Naganawa; Tomoka Hagihara; Hiromi Tsumaki; Tomo Kubo; Maho Sato; Masataka Taguri; Satoshi Morita; Toru Eguchi; Kaoru Kubota; Sadamoto Zenda
Journal:  Support Care Cancer       Date:  2016-02-18       Impact factor: 3.603

3.  The UK Expert Patients Program: lessons learned and implications for cancer survivors' self-care support programs.

Authors:  Patricia M Wilson
Journal:  J Cancer Surviv       Date:  2008-03       Impact factor: 4.442

4.  Psychosocial Interventions for Patients With Advanced Cancer and Their Families.

Authors:  Hoda Badr
Journal:  Am J Lifestyle Med       Date:  2014-04-17

5.  Oral mucositis induced by anticancer treatments: physiopathology and treatments.

Authors:  D'Hondt Lionel; Lonchay Christophe; André Marc; Canon Jean-Luc
Journal:  Ther Clin Risk Manag       Date:  2006-06       Impact factor: 2.423

6.  Cancer treatment-induced mucositis pain: strategies for assessment and management.

Authors:  Debra J Harris
Journal:  Ther Clin Risk Manag       Date:  2006-09       Impact factor: 2.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.